drugset / Trial / NCT00560781
Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will test the therapeutic potential of augmenting a stable SSRI regimen with the neurosteroid pregnenolone to reduce cognitive symptoms and PTSD symptoms in patients diagnosed with PTSD.
Timeline
- Start
- 2006-04
- Primary completion
- 2007-04
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregnenolone | Other / unclassified | 50 mg | — |
| Comparator | Pregnenolone | Other / unclassified | 150 mg | — |
| Comparator | Pregnenolone | Other / unclassified | 250 mg | — |